The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Influence of the APOA5 locus on plasma triglyceride, lipoprotein subclasses, and CVD risk in the Framingham Heart Study
Open accessAbstract
Several polymorphisms in the APOA5 gene have been associated with increased plasma triglyceride (TG) concentrations. However, associations between APOA5 and lipoprotein subclasses, remnant-like particles (RLPs), and cardiovascular disease (CVD) risk have been less explored. We investigated associations of five APOA5 single-nucleotide polymorphisms (SNPs; -1131T>C, -3A>G, 56C>G IVS3+ 476G>A, and 1259T>C) with lipoprotein subfractions and CVD risk in 1,129 men and 1,262 women participating in the Framingham Heart Study. Except for the 56C>G SNP, the other SNPs were in significant linkage disequilibria, resulting in three haplotypes (11111, 22122, and 11211) representing 98% of the population. SNP analyses revealed that the -1131T>C and 56C>G SNPs were significantly associated with higher plasma TG concentrations in both men and women. For RLP and lipoprotein subclasses, we observed gender-specific association for the -1131T>C and 56C>G SNPs. Female carriers of the -1131C allele had higher RLP concentrations, whereas in males, significant associations for RLPs were observed for the 56G allele. Moreover, haplotype analyses confirmed these findings and revealed that the 22122 and 11211 haplotypes exhibited different associations with HDL cholesterol concentrations. In women, the -1131C allele was associated with a higher hazard ratio for CVD (1.85; 95% confidence interval, 1.03-3.34; P = 0.04), in agreement with the association of this SNP with higher RLPs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The minor allele of rs3135506 (minor allele frequency (MAF) of about 6% in whites) has been repeatedly associated with increased plasma TG concentrations [96–99].”
From Fenofibrate and metabolic syndrome (2010) · cites this paper as [97]
Citations
Cites
Improved Prediction of Signal Peptides: SignalP 3.0
Dyrløv Bendtsen, J., Nielsen, H., von Heijne, G., & Brunak, S. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.05.028 · Cited by 6,350
No adjustments are needed for multiple comparisons.
Rothman, K. J. (1990) · Epidemiology · doi:10.1097/00001648-199001000-00010 · Cited by 5,965
The PSIPRED protein structure prediction server
McGuffin, L. J., Bryson, K., & Jones, D. T. (2000) · Bioinformatics · doi:10.1093/bioinformatics/16.4.404 · Cited by 3,887
Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population.
(1995) · Molecular Biology and Evolution · doi:10.1093/oxfordjournals.molbev.a040269 · Cited by 1,950
Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion
den Dunnen, J. T., & Antonarakis, S. E. (2000) · Human Mutation · doi:10.1002/(sici)1098-1004(200001)15:1 · Cited by 1,757
Atherogenesis: a postprandial phenomenon.
Zilversmit, D. B. (1979) · Circulation · doi:10.1161/01.cir.60.3.473 · Cited by 1,701
Combining evolutionary information and neural networks to predict protein secondary structure
Rost, B., & Sander, C. (1994) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.340190108 · Cited by 1,443
Weir, B. S. (1990) · Cited by 1,401
The framingham offspring study. Design and preliminary data
Feinleib, M., Kannel, W. B., Garrison, R. J., McNamara, P. M., & Castelli, W. P. (1975) · Preventive Medicine · doi:10.1016/0091-7435(75)90037-7 · Cited by 926
An Apolipoprotein Influencing Triglycerides in Humans and Mice Revealed by Comparative Sequencing
Pennacchio, L. A., Olivier, M., Hubacek, J. A., Cohen, J. C., Cox, D. R., Fruchart, J.-C., Krauss, R. M., & Rubin, E. M. (2001) · Science · doi:10.1126/science.1064852 · Cited by 921
Flagged first, then by citations
Research works printed but not linked: 1
- Nakajima, 1996, Separation and determination of remnant-like particles in human serum using monoclonal antibodies to apo B and apo A-I, J. Clin. Ligand., 19, 177
Cited by
Sorted by citations
Items 101–162 of 162
Differential regulation of the human versus the mouse apolipoprotein AV gene by PPARalpha
Prieur, X., Lesnik, P., Moreau, M., Rodríguez, J. C., Doucet, C., Chapman, M. J., & Huby, T. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.03.015 · Cited by 18
Lahiry, P., Ban, M. R., Pollex, R. L., Sawyez, C. G., Huff, M. W., Young, T. K., Bjerregaard, P., & Hegele, R. A. (2007) · International Journal of Circumpolar Health · doi:10.3402/ijch.v66i5.18311 · Cited by 17
Kashyap, S., Kumar, S., Agarwal, V., Misra, D. P., Rai, M. K., & Kapoor, A. (2018) · Gene · doi:10.1016/j.gene.2018.01.021 · Cited by 17
Apolipoprotein A5 T-1131C variant and risk for metabolic syndrome in obese adolescents
Zaki, M. E., & Amr, K. S. (2013) · Gene · doi:10.1016/j.gene.2013.10.032 · Cited by 16
Ma, W., Huang, T., Wang, M., Zheng, Y., Wang, T., Heianza, Y., Sun, D., Smith, S. R., Bray, G. A., Sacks, F. M., et al. (2016) · International Journal of Obesity · doi:10.1038/ijo.2016.128 · Cited by 16
Mendelian randomisation, triglycerides, and CHD
Paré, G., & Anand, S. S. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60659-9 · Cited by 16
Plasma apolipoprotein AV levels in mice are positively associated with plasma triglyceride levels
Vaessen, S. F. C., Dallinga‐Thie, G. M., Ross, C. J., Splint, L. J., Castellani, L. W., Rensen, P. C. N., Hayden, M. R., Schaap, F. G., & Kuivenhoven, J. A. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m800551-jlr200 · Cited by 16
Association of apolipoprotein A5 gene variants with metabolic syndrome in Tunisian population
Kéfi, R., Hechmi, M., Dallali, H., Elouej, S., Jmel, H., Halima, Y. B., Nagara, M., Chargui, M., Fadhel, S. B., Romdhane, S., et al. (2017) · Annales d Endocrinologie · doi:10.1016/j.ando.2017.01.005 · Cited by 16
Glucose Regulates the Expression of the Apolipoprotein A5 Gene
Nowak, M., Helleboid‐Chapman, A., Jäkel, H., Moitrot, E., Rommens, C., Pennacchio, L. A., Fruchart‐Najib, J., & Fruchart, J. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.04.057 · Cited by 16
Bhanushali, A. A., & Das, B. R. (2010) · Journal of Community Genetics · doi:10.1007/s12687-010-0025-x · Cited by 17
Liu, X.-T., Sun, J., Li, H. Y., Zhang, L., & Qian, B. C. (2000) · PubMed · Cited by 14
Prochaska, C. L., Picheth, G., Anghebem, M. I., Costantini, C. O., de Souza, E. M., Pedrosa, F. O., & Scartezini, M. (2010) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2010.070 · Cited by 13
Hua, S., Ma, C., Zhang, J., Li, J., Wu, W., Xu, N., Luo, G., & Zhao, J. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00352 · Cited by 12
Evans, D., Bode, A. M., Lippe, G. V. D., Beil, F., & Mann, W. A. (2011) · European journal of medical research · doi:10.1186/2047-783x-16-2-79 · Cited by 13
Lipids in Children and Links to Adult Vascular Disease.
Coakley, J. C. (2018) · Europe PMC (PubMed Central) · Cited by 12
Association of the apolipoprotein M gene polymorphisms and serum lipid levels
Aung, L. H. H., Yin, R., Wu, D., Yan, T.-T., Li, Q., Wu, J., Lin, W., Liu, C., & Pan, S. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-2240-5 · Cited by 11
Iannuzzi, A., Annunziata, M., Fortunato, G., Giacobbe, C., Palma, D., Bresciani, A., Aliberti, E., & Iannuzzo, G. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.832890 · Cited by 10
Ibi, D., Boot, M., Dollé, M. E. T., Jukema, J. W., Rosendaal, F. R., Christodoulides, C., Neville, M. J., Koivula, R., Rensen, P. C. N., Karpe, F., et al. (2022) · Journal of Lipid Research · doi:10.1016/j.jlr.2022.100193 · Cited by 9
Huang, W. Y., Bi, N., Zhang, X., Wang, Y., Chen, B., & Liu, C. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.05.072 · Cited by 9
Association of APOA5 T1131C polymorphism and risk of coronary artery disease.
Xia, J., Cai, W., & Peng, C. (2015) · Europe PMC (PubMed Central) · Cited by 8
A novel mutation of the apolipoprotein A-I gene in a family with familial combined hyperlipidemia
Pisciotta, L., Fasano, T., Calabresi, L., Bellocchio, A., Fresa, R., Borrini, C., Calandra, S., & Bertolini, S. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.09.017 · Cited by 8
Polymorphism of apolipoprotein A5 is a risk factor for cerebral infarction in type 2 diabetes
Li, X., Xu, Y., Ding, Y., Qin, C., Dai, Z., & Niu, L. (2008) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-008-0608-5 · Cited by 7
Association analysis of APOA5 rs662799 and rs3135506 polymorphisms with obesity in Moroccan patients
el yaagoubi, F. L., Charoute, H., Bakhchane, A., Ajjemami, M., Benrahma, H., Errouagui, A., Kandil, M., Rouba, H., & Barakat, A. (2015) · Pathologie Biologie · doi:10.1016/j.patbio.2015.09.002 · Cited by 7
Impacto de la apolipoproteína A5 en el riesgo cardiovascular: Modulaciones genéticas y ambientales
Sotos‐Prieto, M., Francès, F., & Corella, D. (2010) · Revista médica de Chile · doi:10.4067/s0034-98872010000700013 · Cited by 8
Self-citationGenetic Diagnosis via Whole Exome Sequencing in Taiwanese Patients with Hypertriglyceridemia.
Chiou, K., Chen, C.-Y., & Charng, M. (2015) · Journal of atherosclerosis and thrombosis · doi:10.5551/jat.29736 · Cited by 8
Sousa, M. O., Alia, P. J., & Pintó, X. (2008) · Medicina Clínica · doi:10.1157/13121105 · Cited by 6
Helleboid‐Chapman, A., Nowak, M., Helleboid, S., Moitrot, E., Rommens, C., Dehondt, H., Héliot, L., Drobecq, H., Fruchart‐Najib, J., & Fruchart, J. (2009) · Cellular Physiology and Biochemistry · doi:10.1159/000257484 · Cited by 7
Vaessen, S. F. C., Sierts, J. A., Kuivenhoven, J. A., & Schaap, F. G. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.12.115 · Cited by 5
Gesteiro, E., Bastida, S., Vázquez‐Velasco, M., Corella, D., Guillén, M., Ordovás, J. M., & Sánchez-Muniz, F. J. (2011) · European Journal of Pediatrics · doi:10.1007/s00431-011-1473-y · Cited by 6
Self-citationValavanis, I. K., Mougiakakou, S. G., Grimaldi, K. A., & Nikita, K. S. (2008) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/iembs.2008.4650240 · Cited by 5
Yang, Y., Walijee, S. M., Jing, J., Zhao, S., & Peng, D. (2012) · Journal of clinical lipidology · doi:10.1016/j.jacl.2012.02.004 · Cited by 3
Zhang, L. F., Jiang, X., Hua, X. C., Lu, Y., & Xu, N. Y. (2009) · animal · doi:10.1017/s175173110999142x · Cited by 3
Salehi, S., Emadi‐Baygi, M., Rezaei, M., Kelishadi, R., & Nikpour, P. (2018) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.42.1.74 · Cited by 3
Chuluun-Erdene, A., Dagdan, B., Sengeragchaa, O., Sanjmyatav, P., & Janlav, M. (2017) · Central Asian Journal of Medical Sciences · doi:10.24079/cajms.2017.06.006 · Cited by 3
The pharmacogenetics of rosuvastatin and implications for treatment: a systematic review
González‐Iglesias, E., Novalbos, J., & Abad‐Santos, F. (2025) · Pharmacogenomics · doi:10.1080/14622416.2025.2547565 · Cited by 2
Genetic Influences on Blood Lipids and Cardiovascular Disease Risk
Pollin, T. I., Ordovás, J. M., & Guevara‐Cruz, M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802928-2.00026-6 · Cited by 2
Nutrition and Diet in the Era of Genomics
Ordovás, J. M., & Corella, D. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-369420-1.00098-6 · Cited by 2
Self-citationSylvers-Davie, K. L., & Davies, B. S. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819460-7.00125-0 · Cited by 2
L’apolipoprotéine AV : un nouvel acteur du métabolisme des triglycérides
Charrière, S., & Moulin, P. (2009) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(09)73620-x · Cited by 1
Nock, N. L. (2016) · Springer eBooks · doi:10.1007/978-3-319-11251-0_12 · Cited by 1
Kathiresan, S., & Rader, D. J. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374934-5.00023-4 · Cited by 1
Ueda, H., Mineo, R., Sugiyama, T., Koseki, M., Itoh, Y., Iwamoto, R., Tamba, S., Yamamoto, K., Yamada, Y., Hiraoka, H., et al. (2024) · Internal Medicine · doi:10.2169/internalmedicine.3946-24 · Cited by 1
Genes and Gene–Environment Interactions in the Pathogenesis of Obesity and the Metabolic Syndrome
Sanoudou, D., Vafiadaki, E., & Mantzoros, C. S. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-453-1_2 · Cited by 1
Nock, N. L. (2023) · Springer eBooks · doi:10.1007/978-3-031-40116-9_12 · Cited by 1
Nutrigénomique: cas pour un terrain commun à la maladie cardiovasculaire et au cancer
Lacoviello, L., Santimone, I., Latella, M. C., de Gaetano, G., & Donati, M. B. (2009) · Bio Tribune Magazine · doi:10.1007/s11834-009-0105-6
Genetic Epidemiology and Lipids: A Pattern So Grand and Complex
Isaacs, A. J. (2007) · RePub (Erasmus University Rotterdam)
Pampín, S., García‐Bailo, B., Ordovás, J. M., & Rodríguez-Rey, J. C. (2009) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/s0214-9168(09)71129-5
Novel factors affecting clearance of triacylglycerol-rich lipoproteins from blood
Nilsson, S. K. (2010)
Ordovás, J. M. (2007) · Future Lipidology · doi:10.2217/17460875.2.2.115
Samadikuchaksaraei, A., Haqparast, S., Khatami, S., Hashemi, M. J., Fasihi‐Ramandi, M., & Fard‐Esfahani, P. (2011) · Laboratory Medicine · doi:10.1309/lmgfu7tat1o0vmil
Genetics of Common Lipid Disorders
Nock, N. L. (2015) · Springer eBooks · doi:10.1007/978-3-319-12125-3_12-1
Maggo, S. D. S. (2011) · Pharmacogenomics · doi:10.2217/pgs.11.57
Daniele, C., & Dutra, T. (2012)
Kathiresan, S., & Rader, D. J. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-369420-1.00055-x
Cardiovascular Manifestations in Schizophrenia
Calorio, F., Catania, C. G., & Rocchetti, M. (2020) · Springer eBooks · doi:10.1007/978-3-030-28008-6_24
Implication de l'apolipoprotéine AV dans le déterminisme des hyperchylomicronémies
Charrière, S., Moulin, P., métaboliques, N. E. D. R. R., & Sciences-Santé, É. D. I. (2009) · OpenGrey (Institut de l'Information Scientifique et Technique)
Cardiovascular Manifestations in Schizophrenia
Calorio, F., Catania, C. G., & Rocchetti, M. (2020) · Springer eBooks · doi:10.1007/978-3-319-90305-7_24-1
Wulff, A. B., Varbo, A., Nordestgaard, A. G., & Nordestgaard, B. G. (2026) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2026.2639678 · Cited by 2
Chen, X., Ning, L., Chen, Z., Ying, Q., Wei, H., Qin, Y., Yusuf, A. M., Wang, Y., Wang, Y., & Wang, Z. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1926464
Apolipoprotein A (ApoA) in Cardiovascular Disorders: Connections and Insights
Hassanein, A., Rajha, H. E., Hamid, M. A., Hashem, I. E.-A., Al-Saady, R., & Pedersen, S. (2026) · Angiology · doi:10.1177/00033197261491118
Gender and Cardiovascular Diseases in Aging
Marı́n-Garcı́a, J., Goldenthal, M. J., & Moe, G. W. P. L. (2007) · Springer eBooks · doi:10.1007/978-0-387-74072-0_10
Metadata
- Authors
- Lai, C.-Q., Demissie, S., Cupples, L. A., Zhu, Y., Adiconis, X., Parnell, L. D., Corella, D., & Ordovas, J. M.
- Affiliations
- Tufts University (US)
- Boston University (US)
- Corresponding author
- Lai, Chao-Qiang
- ORCID
- Venue
- Journal of Lipid Research
- Publisher
- Elsevier BV
- Published
- 2004-11
- Volume
- 45
- Issue
- 11
- Pages
- 2096-2105
- ISSN
- 0022-2275 (ISSN-L)
- OpenAlex
- W2154292243
- Cited by
- 163
- References
- 59
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 1 · 2023: 2 · 2022: 4 · 2021: 1 · 2020: 2 · 2019: 1 · 2018: 6 · 2017: 5 · 2016: 4 · 2015: 5 · 2014: 6 · 2013: 1 · 2012: 11
- FWCI
- 9.82
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Lipid Research (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Heart, Lung, and Blood Institute (HL54776, R01HL054776)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- APOA5, apolipoprotein A-I, single nucleotide polymorphisms, plasma triglycerides, remnant-like particles, lipoprotein subclasses, cardiovascular risk, HDL cholesterol, haplotypes, linkage disequilibrium, sex differences, Framingham Heart Study
- MeSH terms
- Apolipoprotein A-V, Adult, Aged, Alleles, Apolipoproteins, Apolipoproteins A, Cardiovascular Diseases, Cardiovascular System, Cholesterol, Coronary Disease, Female, Genotype, Haplotypes, Humans, Lipoproteins, Male, Middle Aged, Polymorphism, Genetic, Risk, Sex Factors, Triglycerides, Genetic Variation, Linkage Disequilibrium, Polymorphism, Single Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
